Skip Nav Destination
Issues
15 March 2013
-
Cover Image
Cover Image
Inactivation of the tumor suppressor p53 frequently occurs in tumors and tumor-associated stromal cells. This study shows that p53 dysfunction in tumor-associated stroma of B16F1 melanoma favors tumor establishment and progression by promoting an inflammatory microenvironment. Using immunofluoresence, it was found that lymphoid-like fibroblastic reticular cells, which express ER-TR7 (green), GP38 (red), and a-SMA (blue), were markedly expanded in the tumor microenvironment lacking functional p53. The expansion of this specialized stromal network was associated with augmented myeloid derived suppressor cells and angiogenesis. For details, see the article by Guo and colleagues on page 1668.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Meeting Reports
Priority Reports
Clinical Studies
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
Edwin P. Hui; Graham S. Taylor; Hui Jia; Brigette B.Y. Ma; Stephen L. Chan; Rosalie Ho; Wai-Lap Wong; Steven Wilson; Benjamin F. Johnson; Ceri Edwards; Deborah D. Stocken; Alan B. Rickinson; Neil M. Steven; Anthony T.C. Chan
Integrated Systems and Technologies
Microenvironment and Immunology
Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
Jonathan Ellermeier; Jiwu Wei; Peter Duewell; Sabine Hoves; Mareike R. Stieg; Tina Adunka; Daniel Noerenberg; Hans-Joachim Anders; Doris Mayr; Hendrik Poeck; Gunther Hartmann; Stefan Endres; Max Schnurr
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike; Shiwen Peng; Geoffrey D. Young; Janis M. Taube; William H. Westra; Belinda Akpeng; Tullia C. Bruno; Jeremy D. Richmon; Hao Wang; Justin A. Bishop; Lieping Chen; Charles G. Drake; Suzanne L. Topalian; Drew M. Pardoll; Sara I. Pai
Molecular and Cellular Pathobiology
Transcription Factor YY1 Contributes to Tumor Growth by Stabilizing Hypoxia Factor HIF-1α in a p53-Independent Manner
Shourong Wu; Vivi Kasim; Mitsunobu R. Kano; Sayaka Tanaka; Shinsuke Ohba; Yutaka Miura; Kanjiro Miyata; Xueying Liu; Ako Matsuhashi; Ung-il Chung; Li Yang; Kazunori Kataoka; Nobuhiro Nishiyama; Makoto Miyagishi
Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer
Wan-chi Lin; Nirakar Rajbhandari; Chengbao Liu; Kazuhito Sakamoto; Qian Zhang; Aleata A. Triplett; Surinder K. Batra; Rene Opavsky; Dean W. Felsher; Dominick J. DiMaio; Michael A. Hollingsworth; John P. Morris, 4th; Matthias Hebrok; Agnieszka K. Witkiewicz; Jonathan R. Brody; Hallgeir Rui; Kay-Uwe Wagner
xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Momoko Yoshikawa; Kenji Tsuchihashi; Takatsugu Ishimoto; Toshifumi Yae; Takeshi Motohara; Eiji Sugihara; Nobuyuki Onishi; Takashi Masuko; Kunio Yoshizawa; Shuichi Kawashiri; Makio Mukai; Seiji Asoda; Hiromasa Kawana; Taneaki Nakagawa; Hideyuki Saya; Osamu Nagano
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis
Miriam Martini; Mariangela Russo; Simona Lamba; Elisa Vitiello; Emily Hannah Crowley; Francesco Sassi; Davide Romanelli; Milo Frattini; Antonio Marchetti; Alberto Bardelli
Tumor and Stem Cell Biology
Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway
David R. Croucher; Falko Hochgräfe; Luxi Zhang; Ling Liu; Ruth J. Lyons; Danny Rickwood; Carole M. Tactacan; Brigid C. Browne; Naveid Ali; Howard Chan; Robert Shearer; David Gallego-Ortega; Darren N. Saunders; Alexander Swarbrick; Roger J. Daly
FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Brett G. Hollier; Agata A. Tinnirello; Steven J. Werden; Kurt W. Evans; Joseph H. Taube; Tapasree Roy Sarkar; Nathalie Sphyris; Maryam Shariati; Sreedevi V. Kumar; Venkata L. Battula; Jason I. Herschkowitz; Rudy Guerra; Jeffrey T. Chang; Naoyuki Miura; Jeffrey M. Rosen; Sendurai A. Mani
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
Charity Atkins; Qi Liu; Elisabeth Minthorn; Shu-Yun Zhang; David J. Figueroa; Katherine Moss; Thomas B. Stanley; Brent Sanders; Aaron Goetz; Nathan Gaul; Anthony E. Choudhry; Hasan Alsaid; Beat M. Jucker; Jeffrey M. Axten; Rakesh Kumar
Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/β-Catenin Pathway in Colorectal Cancer
Jordi Camps; Jason J. Pitt; Georg Emons; Amanda B. Hummon; Chanelle M. Case; Marian Grade; Tamara L. Jones; Quang T. Nguyen; B. Michael Ghadimi; Tim Beissbarth; Michael J. Difilippantonio; Natasha J. Caplen; Thomas Ried
Correction
Advertisement